Cell death associated with genetic prodrug activation therapy of colorectal cancer

Cancer Letters

Volumn 174, Issue 1, 2001, Pages 25-33

  Todryk, Stephen ^a   Melcher, Alan ^b   Bottley, Graham ^a   Gough, Michael ^c   Vile, Richard ^c  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c MAYO CLINIC   (United States)

Author keywords

Cell death; Colorectal cancer; Gene therapy; Genetic prodrug activation therapy; Immunity

Indexed keywords

DNA FRAGMENT; GANCICLOVIR; PRODRUG; PROPIDIUM IODIDE; THYMIDINE KINASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DEATH; CELL KILLING; COLORECTAL CANCER; CONTROLLED STUDY; DRUG ACTIVATION; GENE THERAPY; GENETIC CODE; HERPES SIMPLEX VIRUS; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL;

ADENOVIRIDAE; ANIMALS; CELL CYCLE; CELL DEATH; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; FLOW CYTOMETRY; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; PRODRUGS; SIMPLEXVIRUS; TETRAZOLIUM SALTS; THIAZOLES; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

HERPES; SIMPLEXVIRUS;

EID: 0035841950     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00679-6     Document Type: Article

References (21)

1. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
2. The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified
3. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component
4. Apoptosis or necrosis for tumor immunotherapy: What's in a name?
5. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
6. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
7. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
8. Tolerance, danger, and the extended family
9. Cell death and cancer: Replacement of apoptotic genes and inactivation of death suppressor genes in therapy
10. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer
11. Can immunotherapy by gene transfer tip the balance against colorectal cancer?
12. Rapid adenoviral transduction of freshly resected tumour explants with therapeutically useful genes provides a rationale for genetic immunotherapy for colorectal cancer
13. A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSVtk or cytokine expression in a murine melanoma model
14. Disabled infectious single-cycle herpes simplex virus as an oncolytic vector for immunotherapy of colorectal cancer
15. Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinase
16. Prostate cancer gene therapy: Herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models
17. Lack of bystander killing in herpes simplex virus thymidine kinase-transduced colon cell lines due to deficient connexin43 gap junction formation
18. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)
19. Apoptosis, oncosis, and necrosis. An overview of cell death
20. Enhancement of tumor killing using a combination of tumor immunization and HSV-tk suicide gene therapy
21. Combined suicide and granulocyte-macrophage colony-stimulating factor gene therapy induces complete tumor regression and generates antitumor immunity